One-year change in cerebral glucose metabolism in patients with Alzheimer's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 16, Issue 4, 2004, Pages 488-492

  Hirono, Nobutsugu ^a   Hashimoto, Mamoru ^b   Ishii, Kazunari ^b   Kazui, Hiroaki ^b   Mori, Etsuro ^b  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; MALE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 10644240740     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.16.4.488     Document Type: Article

References (35)

1. Grady CL, Haxby JV, Horwitz B, et al.: Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988; 10:576-596
2. Smith GS, de Leon MJ, George AE, et al.: Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease: pathophysiologic implications. Arch Neurol 1992; 49:1142-1150
3. Brown DR, Hunter R, Wyper DJ, et al.: Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. J Psychiatr Res 1996; 30:109-126
4. Sachdev P, Gaur R, Brodaty H, et al.: Longitudinal study of cerebral blood flow in Alzheimer's disease using single photon emission tomography. Psychiatry Res 1997; 68:133-141
5. Lehtovirta M, Kuikka J, Helisalmi S, et al: Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J Neurol Neurosurg Psychiatry 1998; 64:742-746
6. Kogure D, Matsuda H, Ohnishi T, et al.: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41:1155-1162
7. Duara R, Grady C, Haxby J, et al.: Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887
8. Jagust WJ, Friedland RP, Budinger TF, et al: Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 1988; 38:909-912
9. Haxby JV, Grady CL, Koss E, et al.: Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990; 47:753-760
10. Friston KJ, Holmes AP, Worsely KJ, et al.: Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapp 1995; 2:189-210
11. Stern RG, Mohs RC, Davidson M, et al.: A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151:390-396
12. Burns A, Jacoby R, Levy R: Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc 1991; 39:39-45
13. McKhann G, Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
14. Hughes CP, Berg L, Danziger WL, et al.: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
15. Mori E, Lee K, Yasuda M, et al.: Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol 2002; 51:209-214
16. Sano M, Devanand DP, Richards M, et al.: A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995; 52:961-966
17. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
18. Mohs RC, Rosen WG, Davis KL: The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19:448-450
19. Hirono N, Mori E, Ishii K, et al.: Regional hypometabolism related to language disturbance in Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9:68-73
20. Hirono N, Mori E, Yasuda M, et al.: Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease. Alzheimer Dis Assoc Dis 1998; 12:362-367
21. Hirono N, Mori E, Ishii K, et al.: Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology, 1998; 50:380-383
22. Hirono N, Mori E, Ishii K, et al.: Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1998; 10:433-439
23. Hirono N, Mori E, Ishii K, et al.: Hypofunction in posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 64:552-554
24. Hirono N, Mori E, Ishii K, et al.: Neuronal substrates for semantic memory: a positron emission tomography study in Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12:15-21
25. Hirono N, Hashimoto M, Yasuda M, et al. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology 2002; 58:743-750
26. Ishii K, Sasaki M, Kitagaki H, et al.: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997; 38:925-928
27. Ishii K, Willoch F, Minoshima S, et al.: Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001; 42:548-557
28. Minoshima S, Frey KA, Foster NL, et al.: Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995; 19:541-547
29. Minoshima S, Giordani B, Berent S, et al: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42:85-94
30. 15O positron emission tomography. Eur J Nucl Med 1997; 24:670-673
31. Matsuda H, Kitayama N, Ohnishi T, et al: Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002; 43:304-311
32. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82:239-259
33. Baron JC, Chetelat G, Desgranges B, et al.: In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14:298-309
34. Ishii K, Sasaki M, Yamaji S, et al.: Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9:317-322
35. Ibanez V, Pietrini P, Alexander GE, et al.: Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998; 50:1585-1593